Library / Regulatory / State map / Virginia
VA · State regulatory reference

Virginia.

Moderate

Virginia permits establishing a bona fide practitioner-patient relationship via telemedicine under Code of Virginia § 54.1-3303, which allows examination through 'face-to-face interactive, two-way, real-time communications' where the standard of care does not require an in-person exam. Compounding under § 54.1-3410.2 requires compliance with USP-NF standards for both sterile and non-sterile compounding and bars regularly compounding 'essentially copies of commercially available' products, reinforced by Board of Pharmacy guidance document 110-36 (effective 2024). No distinctive statewide restriction or documented peptide/GLP-1 enforcement pattern was found.

Last reviewed · 2026-05-25 · verified entry
Agencies
TPC notes
Telehealth
Under § 54.1-3303, a prescriber may establish a bona fide practitioner-patient relationship via synchronous audio-video without a prior in-person visit when a history is reviewed, a diagnosis is made, and the standard of care does not require an in-person exam; audio-only, email, fax, or a questionnaire alone do not qualify.
Compounding
The Board of Pharmacy adopts USP-NF standards (795 non-sterile, 797 sterile) and enforces them at inspection per § 54.1-3410.2 and guidance doc 110-36; the statute also prohibits regularly compounding copies of commercially available products and restricts permissible bulk drug substances.
Sources
  1. 01 Code of Virginia § 54.1-3303 (prescriptions/telemedicine; bona fide practitioner-patient relationship) ↗
  2. 02 Code of Virginia § 54.1-3410.2 (pharmacist compounding authority; USP-NF standards) ↗
  3. 03 Virginia Board of Pharmacy — Guidance Documents (incl. 110-36, Compliance with USP Standards for Compounding, 2024) ↗
← Back to state map